Sharh maqola

Role of Genetic Testing in Inherited Cardiovascular Disease

Allison L. CirinoCardiovascular Division, Brigham and Women’s Hospital, Boston, MassachusettsStephanie HarrisCardiovascular Division, Brigham and Women’s Hospital, Boston, MassachusettsNeal K. LakdawalaCardiovascular Division, Brigham and Women’s Hospital, Boston, MassachusettsMichelle MichelsDepartment of Cardiology, The Thoraxcenter, Erasmus University Medical Center, Rotterdam, the NetherlandsIacopo OlivottoReferral Centre for Myocardial Diseases, Careggi University Hospital, Florence, ItalySharlene M. DayCardiovascular Division, Department of Internal Medicine, University of Michigan, Ann ArborDominic J. AbramsInherited Cardiac Arrhythmia Program, Division of Cardiac Electrophysiology, Boston Children's Hospital, Boston, MassachusettsPhilippe CharronReferral Center for Cardiac Hereditary Diseases, Assistance Publique–Hôpitaux de Paris, Institute of Cardiometabolism and Nutrition, Hôpital de la Pitié-Salpêtrière, Paris, FranceColleen CaleshuStanford Center for Inherited Cardiovascular Disease, Stanford, CaliforniaChristopher SemsarianAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, University of Sydney, Sydney, AustraliaJodie InglesAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, University of Sydney, Sydney, AustraliaHarry RakowskiDepartment of Medicine, University of Toronto, Toronto, Ontario, CanadaDaniel P. JudgeDivision of Cardiology, Johns Hopkins University, Baltimore, MarylandCarolyn Y. HoCardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts

2017en

ABI

Annotatsiya

Importance: Genetic testing is a valuable tool for managing inherited cardiovascular disease in patients and families, including hypertrophic, dilated, and arrhythmogenic cardiomyopathies and inherited arrhythmias. By identifying the molecular etiology of disease, genetic testing can improve diagnostic accuracy and refine family management. However, unique features associated with genetic testing affect the interpretation and application of results and differentiate it from traditional laboratory-based diagnostics. Clinicians and patients must have accurate and realistic expectations about the yield of genetic testing and its role in management. Familiarity with the rationale, implications, benefits, and limitations of genetic testing is essential to achieve the best possible outcomes. Observations: Successfully incorporating genetic testing into clinical practice requires (1) recognizing when inherited cardiovascular disease may be present, (2) identifying appropriate individuals in the family for testing, (3) selecting the appropriate genetic test, (4) understanding the complexities of result interpretation, and (5) effectively communicating the results and implications to the patient and family. Obtaining a detailed family history is critical to identify families who will benefit from genetic testing, determine the best strategy, and interpret results. Instead of focusing on an individual patient, genetic testing requires consideration of the family as a unit. Consolidation of care in centers with a high level of expertise is recommended. Clinicians without expertise in genetic testing will benefit from establishing referral or consultative networks with experienced clinicans in specialized multidisciplinary clinics. Conclusions and Relevance: Genetic testing provides a foundation for transitioning to more precise and individualized management. By distinguishing phenotypic subgroups, identifying disease mechanisms, and focusing family care, gene-based diagnosis can improve management. Successful integration of genetic testing into clinical practice requires understanding of the complexities of testing and effective communication of the implications to patients and families.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1001/jamacardio.2017.2352

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar